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Abstract
Resveratrol has been widely reported to reduce cancer progression in model systems and to selectively induce cell death in
transformed cell lines. Many enzymes have been reported to respond to resveratrol in mammalian cells, including the
Ataxia-Telangiectasia Mutated (ATM) protein kinase that acts in DNA damage recognition, signaling, and repair. Here we
investigate the responses of ATM to resveratrol exposure in normal and transformed human cell lines and find that ATM
autophosphorylation and substrate phosphorylation is stimulated by resveratrol in a manner that is promoted by reactive
oxygen species (ROS). We observe direct stimulatory effects of resveratrol on purified ATM in vitro and find that the catalytic
efficiency of the kinase on a model substrate is increased by resveratrol. In the purified system we also observe a
requirement for oxidation, as the effect of resveratrol on ATM signaling is substantially reduced by agents that prevent
disulfide bond formation in ATM. These results demonstrate that resveratrol effects on ATM are direct, and suggest a
mechanism by which the oxidizing environment of transformed cells promotes ATM activity and blocks cell proliferation.
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Introduction
Resveratrol (trans-3,49,5-trihyrodoxystilbene) is a naturally-
occurring phenolic compound that is well-known for its cardio-
protective, anti-carcinogenic, anti-inflammatory, and anti-aging
properties in animal model systems [1,2]. In cancer cells,
resveratrol inhibits cell cycle progression, induces apoptosis, and
affects autophagy through multiple mechanisms [3,4]. Resveratrol
also has been reported to inhibit tumor invasion and angiogenesis
by controlling matrix metalloproteinases, vascular endothelial
growth factor, and a number of kinases involved in cell growth
control [5]. The mechanism of resveratrol action has been widely
debated and attributed to many targets, including SIRT1,
cyclooxygenase 1, and AMP-activated protein kinase [6,7].
Although resveratrol is generally considered to be a anti-oxidant
because it induces anti-oxidant enzymes including superoxide
dismutase and glutathione S-transferase [8], other reports have
indicated pro-oxidant effects that initiate growth arrest and
senescence in cancer cells [9,10].
Ataxia Telangiectasia Mutated (ATM) is a serine/threonine
kinase that is activated by DNA damage through interactions with
the Mre11/Rad50/Nbs1 (MRN) complex that recognizes double-
strand breaks in DNA and activates the kinase at damage sites
[11,12]. ATM can also be activated in the absence of MRN or
DNA damage by direct oxidation and generation of disulfide
bonds within the homodimer complex [13,14]. ATM phosphor-
ylates numerous downstream target proteins that are involved in
cell cycle checkpoint activation, DNA repair, and apoptosis
[15,16] and affects many diverse cellular processes including
autophagy, senescence, and mitochondrial functions [17].
A link between resveratrol and ATM has emerged in recent
years from studies suggesting that some of the effects of resveratrol
on cell cycle arrest and apoptosis take place through an ATM-
dependent signaling pathway [9,18–21]. Incubation of human
cancer cell lines with resveratrol was shown to lead to S phase cell
cycle arrest or senescence that could be blocked by caffeine (an
inhibitor of both ATM and the related ATR protein kinase) or by
an ATM-specific inhibitor [9,18]. In addition, resveratrol was
shown to stimulate ATM autophosphorylation as well as
phosphorylation of p53 and Nbs1, but not in caffeine-treated
cells or in cells lacking ATM [19]. In this study, resveratrol did not
efficiently induce p53 phosphorylation in Nijmegen breakage
syndrome (NBS) cells that lack wild-type MRN complex even
though ATM autophosphorylation was stimulated, suggesting that
resveratrol is upstream of the MRN complex and the MRN
complex is required for efficient signal transduction to ATM
downstream. In some of these studies c-H2AX was observed in
response to resveratrol treatment, suggesting that resveratrol either
induces DNA damage or potentiates it with higher levels of
reactive oxygen species (ROS) [18,21], although the mechanism of
ATM stimulation by resveratrol, as with many proposed
resveratrol targets, is unknown. In this work, we focus on the
PLOS ONE | www.plosone.org 1 June 2014 | Volume 9 | Issue 6 | e97969effects of resveratrol on ATM-dependent phosphorylation events
in human cell lines as well in a reconstituted enzyme assay in vitro.
Surprisingly, we find that resveratrol appears to directly activate
ATM in both contexts and requires an oxidizing environment to
exert these effects.
Materials and Methods
Reagents
Commercial reagents included resveratrol (Sigma, R5010-
100 mg), KU-55933 (EMD, 80017-420), TCEP (Pierce, 20490),
NAC (Fisher Scientific, 01049-25), genistein (Sigma, G6649-
25MG), and piceatannol (Sigma, P0453-5MG).
Cell culture and damage treatments
Human HEK293T (ATCC), HCT116 (ATCC), and GM08399
(Coriell) cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM, Invitrogen) supplemented with 10% fetal bovine serum
(FBS)(Invitrogen). Cells were treated with resveratrol (0.1 mM) as
indicated in the figure legends, in DMEM media without FBS.
Treatments with H2O2 or bleomycin were for 30 minutes
immediately before harvesting. Preparation of ATM shRNA
lentivirus: 293T cells were cotransfected for 12 h with ATM
shRNA plasmid (sc-29761-SH, Santa Cruz Biotechnology) and the
lenti-viral packaging constructs VSVG and Delta 8.9 (ratio=2.5
ATM shRNA plasmid: 1.5 Delta 8.9: 1 VSVG) using lipofecta-
mine 2000 reagent (Invitrogen) according to manufacturer
instructions. 48 and 72 hours after transfection, the medium
containing virus was collected, pooled, and filtered using a
0.45 mM syringe filter. The virus was then applied to the
GM08399 fibroblasts, cultured for 24 hours, followed by selection
with puromycin (1 mg/ml) (Invitrogen) for 3 days before testing for
ATM depletion.
Immunocytochemistry and microscopy
293T and GM08399 cells were seeded on chamber slides and
grown for 48 hr. Cells were incubated in the presence or absence
of resveratrol (0.1 mM) for 30 min in DMEM media (Invitrogen)
without FBS. Then cells were treated with H2O2 (0.1 mM) or
bleomycin (1 mg/ml) for 30 min and permeabilized with cold
100% methanol for 5 min. Each step was followed by washing
with PBS 3 times for 5 min. Cells were incubated with 8% bovine
serum albumin (BSA) in PBS for 1 hr and washed with PBS for
5 min. The primary antibody against c-H2AX (GTX80694,
Genetex) was diluted 1:750 in 1% BSA/PBS and added for 1 hr,
followed by washing with PBS 3 times for 5 min. The secondary
antibody against mouse IgG Alexa Fluor 488 (A21202, Invitrogen)
was diluted 1:500 in 1% BSA/PBS and added for 30 min,
followed by washing with PBS 3 times for 5 min. Cells were
counterstained with 49,6-diamino-2phenylindole (DAPI) (D3571,
Invitrogen) at 1:30,000 for 5 min in PBS. Cells were washed with
PBS 3 times for 5 min and washed with water. Chambers were
separated and cover slips were placed after adding one drop of
gold antifade (P36934, Invitrogen). For foci counting, cells were
imaged on a Zeiss Axiovert 200M fluorescence microscope with
100W Hg lamp excitation using AxioVision software. For images
of cells, a Zeiss LSM 710 confocal microscope was used, controlled
by Zen software. The number of foci and c-H2AX signal in
nucleus were analyzed with ImageJ.
Comet assay
GM08399 cells were treated with resveratrol (0.1 mM) or
bleomycin (1 mg/ml) as indicated in the figure legend for 30 min
before harvesting. Alkaline comet assays were performed using
OxiSelect comet assay kit (STA-350, Cell Biolabs) following the
manufacturer’s protocol. Samples were observed under a Zeiss
Axiovert 200M fluorescence microscope.
Western Blotting
Cells were lysed in cell lysis buffer (9803, Cell Signaling) and
lysate (10 mg) was separated by SDS-PAGE and analyzed by
western blotting. Proteins were transferred to PVDF-FL mem-
brane (Millipore) and probed with antibodies directed against
ATM (GRX70103, Genetex), phospho-ATM Ser-1981 (AF-1655,
R&D Systems), p53 (GTX70214, Genetex), phospho-p53 Ser-15
(9286, Cell Signaling), Smc1 (4802, Cell Signaling), phospho-Smc1
Ser-957(4805S, Cell Signaling), Kap1 (ab22553, Abcam), phos-
pho-Kap1 Ser-824 (A300-767A, Bethyl Laboratories), Nbs1
(GTX70224, Genetex), phospho-Nbs1 Ser-343 (ab47272, Abcam),
Chk2 (GTX70295, Genetex), and phospho-Chk2 Thr-68 (2661S,
Cell Signaling) followed by detection with IRdye 800 anti-mouse
(Rockland, RL-610-132-121) or Alexa Fluor 680 anti-rabbit
(Invitrogen, A21076) secondary antibodies. Western blots were
analyzed and quantitated using a Licor Odyssey system.
ATM kinase activity kinetics
ATM (0.36 nM) was incubated with various concentrations of
substrate GST-p53 [22](40, 60, 80, 100, 120, 140, 160, and
320 nM) and H2O2 (817 mM) in the presence or absence of
resveratrol (278 mM) for various incubation times (0, 5, 10, 20, 40,
80, 140, 200, and 240 min). Proteins were transferred to PVDF-
FL membrane and probed with antibody directed against
phospho-p53 Ser-15 followed by detection with Alexa Fluor 680
anti-rabbit secondary antibody. The signal of phosphorylated p53
in each reaction was quantitated using a Licor Odyssey System
and converted to actual concentration of phosphorylated p53 by
comparison to a phosphorylated standard, which was determined
by quantitation of the phosphorylated product. Vmax and Km were
analyzed using Prism software.
Results and Discussion
Resveratrol activates ATM in human cells
Previous experiments have indicated that resveratrol treatment
increases levels of ATM activation in human ovarian cancer cell
lines [18], HCT116 colon carcinoma cells [9], and in immortal-
ized lymphoblastoid cell lines [19]. These studies showed increased
levels of ATM autophosphorylation on Ser-1981 and phosphor-
ylation of Nbs1, p53, and Chk2, suggesting that resveratrol
activates ATM to phosphorylate its targets. While these results are
largely in agreement, it was unclear how resveratrol activates
ATM. One study suggested that resveratrol induces oxidative
stress, which is responsible for the activation [9], while other
studies have indicated that DNA damage is caused by resveratrol
treatment, as measured by c-H2AX formation [18]. To investigate
this phenomenon further, we examined the effects of resveratrol
treatment on ATM-related phosphorylation events in the human
cell lines HEK293T and HCT116.
As shown in Fig. 1A and B, resveratrol treatment does induce
ATM autophosphorylation on ser1981 as well as phosphorylation
of p53 on ser15 in HEK293T cells, consistent with previous
reports. Treatment of cells with bleomycin to induce DNA double-
strand breaks or H2O2 to increase oxidative stress also induced this
effect, and treatment with both resveratrol and bleomycin or
resveratrol and peroxide increased ATM autophosphorylation and
p53 phosphorylation by 2.5-fold +/20.6 relative to either
treatment alone. These phosphorylation events were largely
blocked by treatment of cells with an ATM-specific inhibitor
ATM Activation by Resveratrol
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e97969Figure 1. Resveratrol activates ATM in transformed human cell lines. (a, b) Human HEK293T cells were treated with 0.01 mM ATM inhibitor
(KU-55933) or vehicle (DMSO) for 1 hour, followed by incubation in media also containing 0.1 mM resveratrol (or DMSO), as indicated. After
30 minutes incubation with resveratrol, H2O2 (0.1 mM) or bleomycin (1 mg/ml) was added as indicated for 30 minutes before harvesting. Western
blotting was performed with with antibodies directed against ATM, phospho-ATM Ser-1981, p53, and phospho-p53 Ser-15 as indicated. (c, d) Human
HEK293T cells were treated with resveratrol, bleomycin, or both as in (a) and probed for c-H2AX foci by immunofluorescence. Cell images (291, 267,
216, and 260 cells, respectively) were analyzed for foci using Image J software, and the average number of foci per cell as well as the percentage of
cells containing .5 foci were quantitated. (e, f) Human HCT116 cells were incubated with KU-55933, resveratrol, H2O2, and bleomycin as in (a, b) but
additional phosphorylation targets were examined using antibodies directed against Smc1, phospho-Smc1 Ser-957, Kap1, phospho-Kap1 Ser-824,
Nbs1, phospho-Nbs1 Ser-343, Chk2, and phospho-Chk2 Thr-68 as indicated.
doi:10.1371/journal.pone.0097969.g001
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(Figure 1A, B). Taken together, these results demonstrate that
resveratrol stimulates ATM kinase activity by itself and also
augments the activation of ATM during DNA damage or
oxidative stress in these cells.
A previous study showed that histone H2AX is phosphorylated
upon resveratrol exposure [18], which is generally interpreted as a
sign of DNA double-strand break formation [24]. To investigate
whether resveratrol also induces breaks under our experimental
conditions, we analyzed c-H2AX formation in HEK293T cells
and found that there is a measurable increase in the number of foci
per cell and in the number of cells in a population exhibiting 5 or
more c-H2AX foci per cell in response to resveratrol exposure
(Fig. 1C, D). Bleomycin treatment was used as a positive control in
the experiment, which induced a much higher level of c-H2AX
foci per cell.
To extend these results, we used the colon carcinoma cell line
HCT116 and analyzed phosphorylation of Smc1, Kap1, Nbs1,
and Chk2 in addition to ATM and p53 phosphorylation (Fig. 1E).
In these cells, resveratrol treatment alone also stimulated
phosphorylation of p53 and Nbs1, as well as ATM autophospho-
rylation. Titration of bleomycin induced the phosphorylation of all
the ATM targets as well as autophosphorylation, but there was
little additional effect of resveratrol apart from a ,2-fold increase
in Chk2 thr68 phosphorylation, and other phosphorylation events
(Kap1, SMC1) were unaffected by resveratrol treatment. In
contrast, simultaneous treatment with H2O2 yielded a different
outcome: autophosphorylation of ATM was unaffected by
resveratrol but phospho-Kap1, phospho-Smc1, and phospho-
Chk2 were increased by 3-fold (Fig. 1F). Incubation with the ATM
inhibitor KU-55933 inhibited all of these phosphorylation events.
Thus resveratrol stimulates ATM-dependent phosphorylation of
several different targets in HCT116 cells. Some targets are
phosphorylated in the presence of resveratrol alone, while others
are phosphorylated only with simultaneous oxidative stress. This
difference was not due to the magnitude of damage elicited by the
two different forms of stress, since resveratrol also did not show
cooperative effects with low levels of bleomycin in this cell line
(Fig. 1E).
To determine if these observations using transformed cells also
apply to normal cells, we used untransformed human fibroblasts
(GM08399)(Fig. 2). The levels of phosphorylation on ATM targets
were largely unchanged in response to resveratrol treatment in
these cells, with the exception of a 2.5-fold increase in
phosphorylated Chk2 (Fig. 2A). A titration of resveratrol in these
cells shows a dose-dependent increase (Fig. S1). Similar to the
observations in HCT116 cells, DNA damage induced by
bleomycin treatment strongly induced phosphorylation of ATM
itself as well as Smc1, Kap1, Nbs1, and p53, yet resveratrol had no
discernible effect on these modifications apart from the effect on
Chk2 (Fig. 2A). In contrast, resveratrol strongly stimulated Kap1
and Smc1 phosphorylation by 6-fold when given simultaneously
with hydrogen peroxide (Fig. 2B, C), and the magnitude of the
increase in the phosphorylation events was dependent on both the
level of peroxide treatment as well as resveratrol. All of these
phosphorylation events are dependent on ATM, since treatment
with KU-55933 or depletion of ATM protein by shRNA
eliminated the phosphorylation (Fig. 2C). We do not know why
there is a much stronger effect of resveratrol on some substrates
compared to others; it is possible that this is related to the affinity
of some substrates for ATM, similar to what we have observed for
effects of MRN [22,25].
We also examined c-H2AX foci in the normal fibroblasts and
found that, in contrast to the transformed cells, resveratrol
treatment alone did not induce an increase in c-H2AX foci,
examining both the average number of foci per cell as well as the
percentage of cells containing 5 or more foci (Fig. 2D). However,
resveratrol treatment increased the number of c-H2AX foci
observed by 2 to 3-fold when given simultaneously with either
bleomycin or peroxide treatment (Fig. 2D, E, F). A titration of
resveratrol also shows a dose response in the number of c-H2AX
foci observed per cell (Fig. S2).
It should be noted here that the quantitation of the immuno-
fluorescence images was performed using Image J-derived software
to count individual foci based on a set of training images. Using
this software, we also analyzed total pan-nuclear c-H2AX signal
per cell, not counting discrete spots but general staining intensity,
in comparison to the background level of c-H2AX in untreated
cells. These results show that resveratrol treatment alone does
increase c-H2AX signal in a pan-nuclear pattern but not in
discrete foci (Fig. 2G; examples of images shown in Fig. 2H). This
is interesting as it suggests a global activation of ATM, not
localized to damage sites, and is reminiscent of pan-nuclear ATM
autophosphorylation observed with treatments that are thought to
alter chromatin structure [26]. We do not think that this increased
c-H2AX is associated with DNA damage, as comet assays showed
no sign of chromosomal DNA fragments with resveratrol
treatment (Fig. 2I, J).
Overall, these results show that the responses in all the cell lines
were similar in that resveratrol had moderate effects on ATM
phosphorylation events when given with DNA damage, but
showed much higher stimulation when exposed simultaneously
with peroxide. In comparison, the HEK293T cells exhibited more
responsiveness to DNA damage in the absence of oxidative stress.
However, since some transformed cell lines are known to have
higher levels of ROS compared to normal cells, it is possible that
higher ROS in HEK293T cells promotes the resveratrol response
to DNA DSBs (see below).
Figure 2. Resveratrol activates ATM in human primary fibroblasts (GM08399) in combination with H2O2 or bleomycin. (a, b) The
effects of resveratrol on human primary fibroblasts were tested as in Figure 1 but with varying levels of H2O2 or bleomycin as shown. (c) To deplete
ATM, the fibroblasts were transduced with lentivirus expressing shRNA directed against ATM shRNA plasmid. After selection with puromycin, cells
were tested for ATM expression and ATM target phosphorylation in combination with KU-55933, resveratrol, H2O2, and bleomycin as in Fig. 1. (d)
Human primary fibroblasts were treated with resveratrol, bleomycin, or both as in (a) and probed for c-H2AX foci by immunofluorescence. Cell
images (82, 83, 78, and 82 cells, respectively, were analyzed for foci using Image J software, and the average number of foci per cell were quantitated.
Error bars show standard error and * indicates comparisons in which p,0.05. (e) Human primary fibroblasts were treated as in (d) and the percentage
of cells containing .5 foci was quantitated. Cell images from 3 independent experiments with a total of 266, 264, 248, and 269 cells, respectively,
were quantitated. (f) Human primary fibroblasts were treated with resveratrol (100 mM), hydrogen peroxide, or both as in (b) and were quantitated for
c-H2AX foci by immunofluorescence. 107, 110, 104, and 106 cells, respectively, were analyzed for foci using Image J software, and the average
number of foci per cell was calculated. (g) Quantitation of total pan-nuclear c-H2AX signal per nucleus in cells treated with resveratrol, H2O2, and
bleomycin as in Fig. 1. The average nuclear signal in untreated cells was normalized to 1. (h) Representative immunofluorescence images with
fibroblasts treated as in (a). (i) Representative comet assay images with fibroblasts treated as in (a). (j) Quantification of comet tail length from
fibroblasts treated as in (a); 30 cells were measured for each condition.
doi:10.1371/journal.pone.0097969.g002
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To determine if the effects of resveratrol on ATM are direct and
whether they require oxidation, we used an in vitro kinase assay
with purified components. As we have shown previously,
recombinant dimeric ATM can be activated over 100-fold by
the addition of the MRN complex and linear DNA [25] or by the
addition of oxidizing reagents such as H2O2 [13]. Here we tested
the effects of resveratrol on ATM using GST-p53 as a model
substrate in vitro, assessing kinase activity with phospho-specific
antibody directed against ser15 and analyzing the reactions with
quantitative western blotting. We found that resveratrol does
stimulate ATM kinase activity by itself and also increases the level
of p53 phosphorylation in the presence of either the MRN
complex and DNA or in the presence of H2O2 by 2 to 3-fold
(Fig. 3A, B), similar to the observations in HCT116 and normal
human fibroblasts. Since ATM is activated by resveratrol in the
reactions with H2O2, in the absence of MRN or DNA, it is clear
that DNA damage is not essential for ATM stimulation by
resveratrol.
To determine the mechanism of resveratrol stimulation of
ATM, an analysis of ATM phosphorylation kinetics was
performed using peroxide as the primary stimulant, measuring
the effects of resveratrol on the rate of phosphorylation using
quantitative western blotting of phospho-p53 (Fig. 3C, D). These
results (summarized in Fig. 3E) show that resveratrol does not
improve the affinity of ATM for its substrate since the Km was
124.2 nM in the absence of resveratrol and 189.2 nM in the
presence of resveratrol. However, the maximum reaction rate
(Vmax) was 3.5-fold higher in the presence of resveratrol:
6.4 nmoles/min/pmole of ATM compared to 1.9 nmoles/min/
pmole of ATM in the absence of resveratrol, indicating that
resveratrol increases ATM catalytic efficiency.
We also analyzed the effects of ATP concentration on
resveratrol effects on ATM, and found that resveratrol activates
ATM more efficiently under limiting ATP conditions (Fig. 3F).
While the increase in substrate phosphorylation seen with
resveratrol is ,3-fold in the presence of 1 mM ATP (our standard
reaction conditions), the fold increase in substrate phosphorylation
in comparison to the reactions without resveratrol are 6.1, 7.3, and
9.0-fold at 500, 250, and 125 mM ATP, respectively. The overall
level of phosphorylation is higher with higher levels of ATP but the
fold stimulation by resveratrol is greater when ATP is limiting.
Resveratrol is one of several natural phenolic compounds that
have been shown to have biologically relevant properties in
mammalian cells. For instance, genistein is in the class of
isoflavonoids and has also been shown to induce ATM kinase
activity in human cells [27,28]. Piceatannol, a hydroxylated
analogue of resveratrol, also shows very similar effects to
resveratrol in cultured cells and animal models, including anti-
oxidant and anti-cancer properties [29]. Here we compared both
genistein and piceatannol to resveratrol in the ATM kinase activity
in vitro and found that piceatannol had very similar effects on
ATM-dependent phosphorylation events in the presence of H2O2
in vitro but genistein did not affect ATM activity (Figure 3G).
Neither compound induced ATM activation in the absence of
H2O2 or DNA damage (Fig. S3). Since genistein has been reported
to act as a topoisomerase poison [30], and markers of DNA
damage were observed in cells treated with genistein [28], it is
likely that this compound activates ATM indirectly by inducing
topoisomerase-generated DNA breaks. In contrast, piceatannol
appears to function similarly to resveratrol and is identical in
structure apart from the additional hydroxyl group (Fig. 3H).
ATM stimulation by resveratrol requires oxidation of ATM
ATM activity is strongly affected by levels of ROS, and multiple
disulfide bonds form between ATM monomers to create a
covalently-linked, active dimer, as previously shown [13]. To
determine if ROS are important for ATM stimulation by resveratrol
in vitro, the disulfide-specific reducing agent TCEP was added to
reactions in which ATM is activated by a combination of MRN,
DNA, and resveratrol (Fig. 4A). This experiment does show a
reduction in the efficiency of resveratrol-dependent ATM stimula-
tion by TCEP, while it has no effect on the MRN/DNA reaction
alone, as shown previously [14].The higher level ofTCEPused here
is sufficient to completely block ATM activation by H2O2 (Fig. 4A).
A similar experiment with the antioxidant N-acetyl cysteine (NAC)
also showed a reduction in the resveratrol-dependent increase inp53
phosphorylation (Fig. 4B), indicating that there is an effect of
oxidation on resveratrol stimulation of ATM but that it is not
absolutely required as it is when ATM is activated by oxidation in
the absence of MRN and DNA [13]. We previously described a
mutantof ATMthat isspecifically deficient inthe oxidation pathway
of ATM activation, C2991L [13]. This mutant can be activated
normally by MRN/DNA but shows no activity when oxidized
because the cysteine that is mutated cannot form the disulfide that is
required for activation via oxidative stress. Surprisingly, when the
C2991L mutant was tested for MRN/DNA-dependent stimulation,
this was increased by the presence of resveratrol, and the increase
was also eliminated by NAC (Fig. 4B). These results suggest that
while oxidation is important for the resveratrol-dependent increase,
this increase does not depend on C2991 oxidation.
To understand what the role of the oxidizing agent is in
resveratrol stimulation of ATM, we performed a 2-stage reaction
in which we first incubated the peroxide with either ATM or
resveratrol in a small volume followed by dilution into the complex
reaction containing the remaining reaction components and the
p53 substrate (Fig. 4C). The preincubation level of H2O2 was high
(400 mM) but the final diluted concentration (10 mM) was lower
than the required amount for in vitro activation. (Note that the
high concentration of H2O2 is required because ATM is stored in
the presence of reducing agent to prevent spontaneous activation).
The results from this experiment show that preincubation of H2O2
with ATM in the first reaction promotes subsequent activation of
ATM by resveratrol in the second reaction. In contrast, resveratrol
preincubation with H2O2 has no effect. This rules out the
possibility that the peroxide is modifying resveratrol in some way,
and suggests that ATM oxidation is required for the full
stimulatory effects of this compound.
Figure 3. Purified ATM is stimulated by resveratrol in vitro. (a) MRN/DNA-dependent ATM activity was tested with 0.36 nM ATM, 2.2 nM
MRN, 50 nM GST-p53, and 10 ng (,140 nM) linear DNA in a 40 ml reaction as described previously [25]. (b) H2O2-dependent ATM activity was
performed with 817 mMH 2O2 in vitro as described previously [13] in the presence of 0, 69.5, 139, 278, or 556 mM resveratrol. (c) ATM kinase assays
were performed with 0.36 nM ATM, 817 mMH 2O2, and varying concentrations of GST-p53 substrate (40, 60, 80, 100, 120, 140, 160, and 320 nM) as
indicated, in the presence or absence of 278 mM resveratrol. Phosphorylated p53 was quantitated using western blotting in comparison to standards,
and the rate of phosphorylation (nmoles/min/pmole ATM) is plotted as a function of p53 substrate concentration (d) Skatchard plot is shown based
on data in (c). (e) Vmax (nmoles/min/pmole ATM) and Km (nM) values calculated from data shown in (d) and (e). (f) ATM kinase assay as in (a) with
817 mMH 2O2, 278 mM resveratrol, and varying levels of ATP as indicated. (g) ATM kinase assays were performed as in (a) except with 100, 278, and
830 mM resveratrol, genistein, or piceatannol in the presence of H2O2. (h) diagrams of resveratrol, genistein, and piceatannol structures.
doi:10.1371/journal.pone.0097969.g003
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PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e97969To test this idea further in cells, we again examined resveratrol
simulation of ATM phosphorylation events in HEK293T cells in
combination with DNA damage induced by bleomycin. Pretreat-
ment of cells with NAC reduced the extent to which resveratrol
promotes ATM phosphorylation of its targets Smc1, Kap1, and
Chk2 (results from 3 experiments quantified in Fig. 4E), but had
little effect on the phosphorylation induced by bleomycin alone.
Overall, these results show that resveratrol directly modulates
the activity of ATM and has effects on both the MRN/DNA
mechanism of activation as well as the oxidation pathway. In
addition, we find that levels of ROS dictate the efficiency of
resveratrol effects on ATM, such that high levels of ROS promote
activation, both in cell lines and in a purified system in vitro. Since
we have previously demonstrated the formation of multiple
disulfide bonds in ATM under oxidizing conditions, it is possible
that the functional effects of resveratrol require conformational
changes dependent on one or more of these disulfide bridges. This
dependence on ROS may form at least part of the basis for
selective effects of resveratrol on cancer cells versus normal cells as
transformation is known to increase levels of ROS [31].
Supporting Information
Figure S1 Human primary fibroblasts were treated with
resveratrol, hydrogen peroxide, or both as in Fig. 2B. The western
blot was probed for phospho-Kap1(S824), Kap1, phospho-
Chk2(T68), and Chk2 as indicated.
(DOCX)
Figure S2 Human primary fibroblasts were treated with
resveratrol, hydrogen peroxide (100 mM), or both as in Fig. 2F.
The number of cH2AX foci per cell was quantitated (84, 92, 85,
80, 84, 93, 93, and 88 cells were counted, respectively) and the
average number of foci per cell is shown with standard error. *
indicates comparisons in which p,0.05.
(DOCX)
Figure S3 ATM kinase assays were performed as in Figure 3G
with 100 mMH 2O2, resveratrol (100 mM), genistein (100 mM) or
piceatannol (100 mM) as indicated.
(DOCX)
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